Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key COVID-19 Studies Influencing My Practice Following IDWeek 2021—Audio Recap

September 29 - October 3, 2021; Virtual
Listen to expert insights from Renslow Sherer, MD, on updates and new COVID-19 data from IDWeek 2021, including prevention, treatment for outpatients and hospitalized patients, and long-term outcomes.
Renslow Sherer, MD
Released: October 29, 2021

In this episode, Renslow Sherer, MD, discusses new COVID-19 data from IDWeek 2021, including:

  • Prevention of COVID-19
    • ChAdOx1 nCoV-19
    • Ad26.COV2.S
    • Tixagevimab plus cilgavimab
  • Outpatients with COVID-19
    • Remdesivir IV
    • Molnupiravir
  • Hospitalized patients with COVID-19
    • Baricitinib
    • Lenzilumab
    • Casirivimab plus imdevimab
  • Long-term COVID-19 outcomes
    • Sustained recovery

Information on this Educational Activity

Faculty

Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Renslow Sherer, MD, has disclosed that he has received an unrestricted research grant from Gilead Sciences.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

Download slides reviewing the latest data and guidance on COVID-19 prevention and treatment in special populations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 18, 2022

Expert insights on new key data from ECCMID 2022 on SARS-CoV-2 and COVID-19, including on diagnosis, prevention, and treatment, as reported by Clinical Care Options (CCO)

Cristina Mussini, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: May 18, 2022 Expired: May 17, 2023

Download slides reviewing the latest data and guidance on COVID-19 symptoms and clinical manifestations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 17, 2022

Downloadable slides from CCO on the rationale and evidence supporting timeliness in the administration of therapies that act directly against SARS-CoV-2

person default Michael G. Ison, MD, MS Arthur Kim, MD Lynora Saxinger, MD, FRCPC, CTropMed Released: May 11, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings